UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
Globalstar
GSAT
$10.8B
| $3.64M | ﹤0.01% |
154,724
+30,782
| +25% | +$620K |
2015 Q2
40 quarters
|
|
1852
Navient
NAVI
$874M
| $3.64M | ﹤0.01% |
258,368
+48,018
| +23% | +$617K |
2014 Q2
44 quarters
|
|
1853
IDT Corp
IDT
$2.05B
| $3.63M | ﹤0.01% |
53,187
+22,025
| +71% | +$1.26M |
2023 Q4
6 quarters
|
|
1854
ANI Pharmaceuticals
ANIP
$1.68B
| $3.63M | ﹤0.01% |
55,624
+7,302
| +15% | +$475K |
2021 Q1
17 quarters
|
|
1855
DXP Enterprises
DXPE
$2.83B
| $3.63M | ﹤0.01% |
41,391
+13,071
| +46% | +$1.09M |
2020 Q3
19 quarters
|
|
1856
US Physical Therapy
USPH
$1.28B
| $3.63M | ﹤0.01% |
46,386
+14,104
| +44% | +$1.04M |
2017 Q4
30 quarters
|
|
1857
Eos Energy Enterprises
EOSE
$889M
| $3.62M | ﹤0.01% |
706,160
+301,109
| +74% | +$1.48M |
2024 Q4
2 quarters
|
|
1858
Healthcare Services Group
HCSG
$1.42B
| $3.61M | ﹤0.01% |
240,486
+111,614
| +87% | +$1.48M |
2013 Q2
48 quarters
|
|
1859
TriCo Bancshares
TCBK
$1.65B
| $3.61M | ﹤0.01% |
89,125
+19,485
| +28% | +$766K |
2014 Q3
43 quarters
|
|
1860
Vera Therapeutics
VERA
$2.03B
| $3.61M | ﹤0.01% |
153,098
+55,085
| +56% | +$1.24M |
2023 Q4
6 quarters
|
|
1861
DELISTED
Treehouse Foods
THS
| $3.61M | ﹤0.01% |
185,678
+66,783
| +56% | +$1.5M |
2013 Q2
48 quarters
|
|
1862
TMC The Metals Company
TMC
$1.28B
| $3.6M | ﹤0.01% |
+545,886
| New | +$2.09M |
2025 Q2
0 quarters
|
|
1863
Grindr
GRND
$2.6B
| $3.6M | ﹤0.01% |
158,702
+89,570
| +130% | +$1.97M |
2024 Q4
2 quarters
|
|
1864
Peoples Bancorp
PEBO
$1.3B
| $3.6M | ﹤0.01% |
117,885
+35,595
| +43% | +$1.04M |
2020 Q2
20 quarters
|
|
1865
1st Source
SRCE
$2.05B
| $3.6M | ﹤0.01% |
58,002
+24,950
| +75% | +$1.48M |
2021 Q1
17 quarters
|
|
1866
TriMas Corp
TRS
$1.36B
| $3.59M | ﹤0.01% |
125,529
+24,107
| +24% | +$591K |
2013 Q2
48 quarters
|
|
1867
Appian
APPN
$2.81B
| $3.59M | ﹤0.01% |
120,106
+30,026
| +33% | +$902K |
2019 Q2
24 quarters
|
|
1868
Penguin Solutions Inc
PENG
$4.06B
| $3.58M | ﹤0.01% |
180,505
+51,084
| +39% | +$924K |
2020 Q4
18 quarters
|
|
1869
Alpha Metallurgical Resources
AMR
$2.38B
| $3.57M | ﹤0.01% |
31,776
+12,579
| +66% | +$1.47M |
2023 Q1
9 quarters
|
|
1870
Fortuna Silver Mines
FSM
$3.17B
| $3.57M | ﹤0.01% |
546,462
-294,034
| -35% | -$1.82M |
2024 Q3
3 quarters
|
|
1871
Birkenstock
BIRK
$5.55B
| $3.57M | ﹤0.01% |
72,638
+100
| +0.1% | +$5.14K |
2024 Q3
3 quarters
|
|
1872
Driven Brands
DRVN
$1.96B
| $3.54M | ﹤0.01% |
201,581
+62,260
| +45% | +$1.07M |
2021 Q2
16 quarters
|
|
1873
MaxLinear
MXL
$8.01B
| $3.54M | ﹤0.01% |
248,900
+66,538
| +36% | +$768K |
2014 Q2
44 quarters
|
|
1874
Liberty Latin America Class C
LILAK
$1.62B
| $3.53M | ﹤0.01% |
625,028
+221,134
| +55% | +$1.08M |
2018 Q3
27 quarters
|
|
1875
Edgewell Personal Care
EPC
$1.3B
| $3.52M | ﹤0.01% |
150,557
+33,430
| +29% | +$927K |
2015 Q3
39 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.